1. Home
  2. WAFD vs ADPT Comparison

WAFD vs ADPT Comparison

Compare WAFD & ADPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo WaFd Inc.

WAFD

WaFd Inc.

HOLD

Current Price

$32.88

Market Cap

2.5B

Sector

Finance

ML Signal

HOLD

Logo Adaptive Biotechnologies Corporation

ADPT

Adaptive Biotechnologies Corporation

HOLD

Current Price

$16.04

Market Cap

2.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WAFD
ADPT
Founded
1917
2009
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.5B
2.8B
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
WAFD
ADPT
Price
$32.88
$16.04
Analyst Decision
Hold
Strong Buy
Analyst Count
5
9
Target Price
$31.90
$17.78
AVG Volume (30 Days)
641.9K
1.9M
Earning Date
01-15-2026
02-05-2026
Dividend Yield
3.28%
N/A
EPS Growth
29.74
N/A
EPS
2.88
N/A
Revenue
$734,465,000.00
$276,976,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$4.15
$23.05
P/E Ratio
$11.42
N/A
Revenue Growth
3.63
54.77
52 Week Low
$23.75
$6.26
52 Week High
$34.30
$20.76

Technical Indicators

Market Signals
Indicator
WAFD
ADPT
Relative Strength Index (RSI) 44.90 35.89
Support Level $32.16 $14.85
Resistance Level $33.60 $17.98
Average True Range (ATR) 0.62 1.10
MACD -0.05 -0.35
Stochastic Oscillator 19.55 14.24

Price Performance

Historical Comparison
WAFD
ADPT

About WAFD WaFd Inc.

WaFd Inc is engaged in providing lending, depository, insurance, and other banking services to consumers, mid-sized to large businesses, and owners and developers of commercial real estate. Through the WaFd Bank, it is involved in accepting deposits from the general public and investing these funds in loans of various types, including first-lien mortgages on single-family dwellings, construction loans, land acquisition and development loans among others. The Bank also invests in certain United States government and agency obligations along with other investments and also performs insurance brokerage activities. Geographically, it operates in Washington, Oregon, Idaho, Arizona, Utah, Nevada, New Mexico, California and Texas.

About ADPT Adaptive Biotechnologies Corporation

Adaptive Biotechnologies Corp is a company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease (MRD) in patients with multiple myeloma (MM), B cell acute lymphoblastic leukemia (ALL) and chronic lymphocytic leukemia (CLL) and is also available as a CLIA-validated laboratory developed test (LDT) for patients with other lymphoid cancers, including diffuse large B-cell lymphoma (DLBCL).

Share on Social Networks: